PX
62
2
DLTR
47
4
IR
77
2
TRIP
49
2
ROP
74
2
DG
32
4
CINF
54
4
GM
63
2
BLK
63
-3
AMT
64
2
HD
47
-2
CCI
36
3
URI
63
-2
SRCL
60
3
VRSK
89
2
DHR
47
-2
MMC
64
11
SLB
56
4
CVS
44
-5
AEP
61
5
PX
62
2
DLTR
47
4
IR
77
2
TRIP
49
2
ROP
74
2
DG
32
4
CINF
54
4
GM
63
2
BLK
63
-3
AMT
64
2
HD
47
-2
CCI
36
3
URI
63
-2
SRCL
60
3
VRSK
89
2
DHR
47
-2
MMC
64
11
SLB
56
4
CVS
44
-5
AEP
61
5
Financhill
Back

Haynes International Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
53

HAYN
Haynes International

Last Price:
58.39
Seasonality Move:
2.54%
Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
40.85
Seasonality Move:
-0.9%
Buy
53
Haynes International (HAYN) is a Buy

Is Haynes International a Buy, Sell or Hold?

  • The current Haynes International [HAYN] share price is $58.45. The Score for HAYN is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • HAYN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HAYN Stock Price Chart

What is Haynes International's stock price today?

  • The Haynes International share price today is $58.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HAYN is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.42
    The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

HAYN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 43.58 Sell
Chaikin Money Flow: 2027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.3 - 58.9) Sell
Bollinger Bands (100): (58.83 - 60.19) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 52.47 Buy
Chaikin Money Flow: 873891 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Buy
Bollinger Bands (100): (40.78 - 48.78) Sell

HAYN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.27 Buy
20-day SMA: 58.54 Sell
50-day SMA: 59.17 Sell
200-day SMA: 54.49 Buy
8-day EMA: 58.37 Buy
20-day EMA: 58.54 Sell
50-day EMA: 58.86 Sell
200-day EMA: 55.79 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.5 Buy
20-day SMA: 40.58 Buy
50-day SMA: 41.51 Sell
200-day SMA: 42.46 Sell
8-day EMA: 40.23 Buy
20-day EMA: 40.49 Buy
50-day EMA: 41.77 Sell
200-day EMA: 43.33 Sell

Haynes International Earnings Growth & HAYN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.31 per share, an increase next quarter of $0.34 per share, a decrease this year of $0.14 per share, and an increase next year of $1.44 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Haynes International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):